(Q50306845)

English

Neurodevelopmental disorders: Glutamate blockers show benefit in models of autism spectrum disorders.

scientific article published in June 2012

In more languages

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22653211

retrieved

2 March 2018

reference URL

http://europepmc.org/abstract/MED/22653211

title

Neurodevelopmental disorders: Glutamate blockers show benefit in models of autism spectrum disorders. (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22653211

retrieved

2 March 2018

reference URL

http://europepmc.org/abstract/MED/22653211

main subject

autism spectrum disorder

0 references

autism

0 references

neurodevelopmental disorder

1 reference

1

Charlotte Harrison

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22653211

retrieved

2 March 2018

reference URL

http://europepmc.org/abstract/MED/22653211

publication date

1 June 2012

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22653211

retrieved

2 March 2018

reference URL

http://europepmc.org/abstract/MED/22653211

published in

Nature Reviews Drug Discovery

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22653211

retrieved

2 March 2018

reference URL

http://europepmc.org/abstract/MED/22653211

volume

11

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22653211

retrieved

2 March 2018

reference URL

http://europepmc.org/abstract/MED/22653211

issue

6

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22653211

retrieved

2 March 2018

reference URL

http://europepmc.org/abstract/MED/22653211

page(s)

440-441

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22653211

retrieved

2 March 2018

reference URL

http://europepmc.org/abstract/MED/22653211

exact match

https://scigraph.springernature.com/pub.10.1038/nrd3761

0 references

cites work

Chronic pharmacological mGlu5 inhibition corrects fragile X in adult mice.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1038%2FNRD3761

retrieved

21 January 2018

Negative allosteric modulation of the mGluR5 receptor reduces repetitive behaviors and rescues social deficits in mouse models of autism

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1038%2FNRD3761

retrieved

21 January 2018

Identifiers

DOI

10.1038/NRD3761

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22653211

retrieved

2 March 2018

reference URL

http://europepmc.org/abstract/MED/22653211

PubMed publication ID

22653211

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22653211

retrieved

2 March 2018

reference URL

http://europepmc.org/abstract/MED/22653211

(Q50306845)

Neurodevelopmental disorders: Glutamate blockers show benefit in models of autism spectrum disorders.

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)